Reply to: “Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered”

Lignende værker

• Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered
  af: Deltenre, Pierre, et al.
  Udgivet: (2021)
• Intravenous ketamine and progressive cholangiopathy in COVID-19 patients
  Udgivet: (2021)
• Ketamine-induced cholangiopathy in ARDS patients
  af: de Tymowski, Christian, et al.
  Udgivet: (2021)
• Reply to “Methodological notes, should be considered in research on Mizaj”
  af: Aghanouri, Zahra, et al.
  Udgivet: (2021)
• Should statins be considered for the management of mucormycosis in COVID-19?
  af: Chatterjee, Subhankar, et al.
  Udgivet: (2021)